James Millis to Immunosuppressive Agents
This is a "connection" page, showing publications James Millis has written about Immunosuppressive Agents.
Connection Strength
1.553
-
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant. 2014 Feb; 14(2):356-66.
Score: 0.327
-
Post-Hoc Analysis of a Randomized, Double Blind, Prospective Study at the University of Chicago: Additional Standardizations of Trial Protocol are Needed to Evaluate the Effect of a CXCR1/2 Inhibitor in Islet Allotransplantation. Cell Transplant. 2021 Jan-Dec; 30:9636897211001774.
Score: 0.132
-
Treatment of liver allograft rejection. Liver Transpl Surg. 1999 Jul; 5(4 Suppl 1):S98-S106.
Score: 0.119
-
Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients. Transplant Proc. 1998 Jun; 30(4):1435-6.
Score: 0.111
-
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy. Transplant Proc. 1997 Feb-Mar; 29(1-2):1549.
Score: 0.101
-
Potential role of Neoral in pediatric liver transplantation. Transplant Proc. 1996 Aug; 28(4):2267-9.
Score: 0.097
-
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Transplant Proc. 1996 Apr; 28(2):1014.
Score: 0.095
-
Coating human pancreatic islets with CD4(+)CD25(high)CD127(-) regulatory T cells as a novel approach for the local immunoprotection. Ann Surg. 2011 Sep; 254(3):512-8; discussion 518-9.
Score: 0.069
-
Liver transplantation for non-hepatocellular carcinoma malignancy: Indications, limitations, and analysis of the current literature. Liver Transpl. 2010 Aug; 16(8):930-42.
Score: 0.064
-
Modern immunosuppression. Clin Liver Dis. 2000 Aug; 4(3):619-55, ix.
Score: 0.032
-
Liver transplantation at the University of Chicago. Clin Transpl. 1999; 231-8.
Score: 0.029
-
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5.
Score: 0.028
-
Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen. Transplant Proc. 1998 Jun; 30(4):1249-50.
Score: 0.028
-
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1378-9.
Score: 0.028
-
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Jun; 30(4):1538-40.
Score: 0.028
-
Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Mar; 30(2):507-8.
Score: 0.027
-
Reversal of accelerated renal allograft rejection with FK 506. Clin Transplant. 1997 Aug; 11(4):251-4.
Score: 0.026
-
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307.
Score: 0.025
-
Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10.
Score: 0.025
-
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
Score: 0.024
-
OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transplant. 1996 Aug; 10(4):389-95.
Score: 0.024
-
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection. Transplantation. 1996 May 15; 61(9):1365-9.
Score: 0.024
-
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Transplant Proc. 1996 Apr; 28(2):998-9.
Score: 0.024
-
Use of immune function test in monitoring immunosuppression in liver transplant recipients. Clin Transplant. 2012 Nov-Dec; 26(6):826-32.
Score: 0.018
-
Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med. 2010 Nov 18; 363(21):2004-14.
Score: 0.016
-
Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Transplantation. 2004 Apr 27; 77(8):1269-75.
Score: 0.010
-
Liver transplantation in the first three months of life. Transplantation. 1998 Sep 15; 66(5):606-9.
Score: 0.007
-
Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation. 1998 Feb 15; 65(3):393-6.
Score: 0.007
-
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. Transplantation. 1996 Aug 15; 62(3):370-5.
Score: 0.006